about
A Critical Appraisal of “Chronic Lyme Disease”Identification of OppA2 linear epitopes as serodiagnostic markers for Lyme disease.Treatment trials for post-Lyme disease symptoms revisited.LcrV capture enzyme-linked immunosorbent assay for detection of Yersinia pestis from human samples.Platform technology to deliver prophylactic molecules orally: an example using the Class A select agent Yersinia pestisAntiscience and ethical concerns associated with advocacy of Lyme disease.Decorin binding proteins A and B in the serodiagnosis of Lyme disease in North America.Cross-Reactive Epitopes in Borrelia burgdorferi p66.Epitope length, genospecies dependency, and serum panel effect in the IR6 enzyme-linked immunosorbent assay for detection of antibodies to Borrelia burgdorferi.Development of a Multiantigen Panel for Improved Detection of Borrelia burgdorferi Infection in Early Lyme Disease.Detection of IFN-γ Secretion by T Cells Collected Before and After Successful Treatment of Early Lyme Disease.Oral immunization with recombinant lactobacillus plantarum induces a protective immune response in mice with Lyme diseaseOral vaccine that breaks the transmission cycle of the Lyme disease spirochete can be delivered via bait.Lymphocyte subsets in women on low dose oral contraceptives.Ventricular tachycardia associated with Lyme carditis.A comparison of two treatment regimens of ceftriaxone in late Lyme disease.Anti-tumor necrosis factor-alpha activation of Borrelia burgdorferi spirochetes in antibiotic-treated murine Lyme borreliosis: an unproven conclusion.Scientific evidence and best patient care practices should guide the ethics of Lyme disease activism.Single-dose prophylaxis against Lyme disease.Ceftriaxone Compared with Doxycycline for the Treatment of Acute Disseminated Lyme DiseaseInvasion of the central nervous system by Borrelia burgdorferi in acute disseminated infectionPositive Lyme serology in subacute bacterial endocarditis. A study of four patientsCross-reactive antigenic domains of the flagellin protein of Borrelia burgdorferiResponse to meta-analysis of Lyme borreliosis symptomsA commentary on the treatment of early lyme diseaseComparison of lyme disease serologic assays and lyme specialty laboratoriesInverted T helper/T suppressor lymphocyte ratio is not a reliable indicator of coexistent HIV infection in the presence of carcinoma: report of a patient with ovarian carcinoma and inverted TH/TS ratioThe reply
P50
Q22248114-9F470C83-9282-47D6-8047-1B50625E3319Q33601926-0818AA28-90C0-4CAC-BDE8-4DD953651B5DQ33822701-E931986C-2C65-467B-87CD-7A4AE7702E32Q33858962-355E3705-F901-4050-BFB8-7C407658482DQ34140454-DDCDA23E-AA01-40C9-9A02-935D21F0E86AQ34210918-21A53CC9-F0F0-4CFD-992C-B3D67625A0A7Q34701380-A812B890-5F19-4335-A4EE-B31DDA06F921Q35773909-0505A54D-99E4-4B35-99AE-C7D0C2E1509CQ35946915-63D291AB-F81D-489A-BDE7-04EC3284E9EBQ36297670-341652E4-38F2-4D37-8C29-E5B195D55E51Q36837894-AE4EB72D-94B6-47A2-85F2-895DFF7156D7Q36898061-E50E54EF-2019-4AF8-99E7-472F326E6540Q43219275-260ABB29-172C-4C4B-B49A-754336B38B64Q43421439-81F3BC94-5DFE-4314-AD08-3F2574313366Q43537158-5726ADC3-472B-4AEB-A99B-5EC8ACC26351Q46625674-54C518B6-0B35-4C6D-9417-E20250073487Q46812263-819E38DE-C3DC-49BF-8C95-427B00FD5822Q48749853-9F0DE191-932F-4E80-BB11-6FDCB567EA98Q52680064-9D5FFDFC-D4B3-4BA4-87AF-22ED84785F3FQ63664757-7A45C6AA-218E-47FE-A734-B3ADA21D5036Q67755859-0EA6409C-4DD6-4382-91E4-5B3C68F14777Q68590283-5509E3B6-0A11-4A45-9695-F27CB28CE857Q71600423-3888C1AC-E6C9-4CE2-A8D8-36943E1C033BQ81555217-7E625D8A-2792-4017-962A-BD982831035BQ82489714-19C0495D-29E1-4E5D-867D-0157D1D83A3CQ85238411-0B176673-568E-4A9B-A35A-554167A477C8Q93512164-C2E4FA4B-7AD4-42ED-888B-D7AFFAB093A7Q95519930-2532713D-5E92-4CF1-9DFA-321AD60E299C
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Raymond J. Dattwyler
@ast
Raymond J. Dattwyler
@en
Raymond J. Dattwyler
@es
Raymond J. Dattwyler
@nl
Raymond J. Dattwyler
@sl
type
label
Raymond J. Dattwyler
@ast
Raymond J. Dattwyler
@en
Raymond J. Dattwyler
@es
Raymond J. Dattwyler
@nl
Raymond J. Dattwyler
@sl
prefLabel
Raymond J. Dattwyler
@ast
Raymond J. Dattwyler
@en
Raymond J. Dattwyler
@es
Raymond J. Dattwyler
@nl
Raymond J. Dattwyler
@sl
P106
P1153
7005111654
P21
P31
P496
0000-0002-1983-1301